JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406400200 on June 11, 2004

J. Biol. Chem., Vol. 279, Issue 39, 40362-40367, September 24, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/39/40362    most recent
M406400200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakamoto, S.
Right arrow Articles by Larner, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakamoto, S.
Right arrow Articles by Larner, A. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Histone Deacetylase Activity Is Required to Recruit RNA Polymerase II to the Promoters of Selected Interferon-stimulated Early Response Genes*

Shuji Sakamoto, Ramesh Potla, and Andrew C. Larner{ddagger}

From the Department of Immunology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195

Posttranslational modification of histones by acetylation, methylation or phosphorylation has emerged as a major mechanism to modify chromatin structure and gene expression. In most cases, transcriptionally active genes display enhanced binding of acetylated histones in their promoters. Activation of histone acetyltransferases or inhibition of histone deacetylases (HDACs) allows chromatin to assume a more open state permitting transcriptional activators to form a preinitiation complex. To our surprise, treatment of cells with the HDAC inhibitor, trichostatin A (TSA), inhibits selected interferon {beta} (IFN{beta})-stimulated immediate early genes that are activated by the transcription factors Stat1 and Stat2. However, IFN{beta} activation of IRF-1, which requires tyrosine-phosphorylated Stat1 homodimers binding to a {gamma} interferon activation sequence in its promoter is not affected by TSA. Exposure of cells to TSA does not alter tyrosine phosphorylation of Stat1 or Stat2. TSA treatment of cells also does not alter the binding of Stat 1 or Stat2 to the endogenous ISG54 promoter. However, IFN{beta}-stimulated binding of RNA polymerase II to the ISG54 promoter is prevented by TSA. Interestingly, ectopic expression of IRF9 reverses the inhibitory actions of TSA, suggesting that IRF9 functions to recruit RNA polymerase II to the promoter of interferon-stimulated genes. This particular function of IRF9 requires the activity of histone deacetylases.


Received for publication, June 8, 2004

* This work was supported by National Institutes of Health Grant CA77366. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed. Tel.: 216-445-9045; Fax: 216-444-8372; E-mail: larnera{at}ccf.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. M. Karp, T. T. Tan, R. Mathew, D. Nelson, C. Mukherjee, K. Degenhardt, V. Karantza-Wadsworth, and E. White
Role of the Polarity Determinant Crumbs in Suppressing Mammalian Epithelial Tumor Progression
Cancer Res., June 1, 2008; 68(11): 4105 - 4115.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. R. Fantin, A. Loboda, C. P. Paweletz, R. C. Hendrickson, J. W. Pierce, J. A. Roth, L. Li, F. Gooden, S. Korenchuk, X. S. Hou, et al.
Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma
Cancer Res., May 15, 2008; 68(10): 3785 - 3794.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Sebastian, M. Serra, A. Yeramian, N. Serrat, J. Lloberas, and A. Celada
Deacetylase Activity Is Required for STAT5-Dependent GM-CSF Functional Activity in Macrophages and Differentiation to Dendritic Cells
J. Immunol., May 1, 2008; 180(9): 5898 - 5906.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
K. Parker, J. Maxson, A. Mooney, and E. A. Wiley
Class I Histone Deacetylase Thd1p Promotes Global Chromatin Condensation in Tetrahymena thermophila
Eukaryot. Cell, October 1, 2007; 6(10): 1913 - 1924.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Ramsauer, M. Farlik, G. Zupkovitz, C. Seiser, A. Kroger, H. Hauser, and T. Decker
Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-{gamma}-inducible gbp2 gene
PNAS, February 20, 2007; 104(8): 2849 - 2854.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Vlasakova, Z. Novakova, L. Rossmeislova, M. Kahle, P. Hozak, and Z. Hodny
Histone deacetylase inhibitors suppress IFN{alpha}-induced up-regulation of promyelocytic leukemia protein
Blood, February 15, 2007; 109(4): 1373 - 1380.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Zupkovitz, J. Tischler, M. Posch, I. Sadzak, K. Ramsauer, G. Egger, R. Grausenburger, N. Schweifer, S. Chiocca, T. Decker, et al.
Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1
Mol. Cell. Biol., November 1, 2006; 26(21): 7913 - 7928.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Overbergh, K. Stoffels, M. Waer, A. Verstuyf, R. Bouillon, and C. Mathieu
Immune Regulation of 25-Hydroxyvitamin D-1{alpha}-Hydroxylase in Human Monocytic THP1 Cells: Mechanisms of Interferon-{gamma}-Mediated Induction
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3566 - 3574.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Nusinzon and C. M. Horvath
Positive and Negative Regulation of the Innate Antiviral Response and Beta Interferon Gene Expression by Deacetylation
Mol. Cell. Biol., April 15, 2006; 26(8): 3106 - 3113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamaguchi, A. Lantowski, A. J. Dannenberg, and K. Subbaramaiah
Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2
J. Biol. Chem., September 23, 2005; 280(38): 32569 - 32577.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
I. Nusinzon and C. M. Horvath
Histone Deacetylases as Transcriptional Activators? Role Reversal in Inducible Gene Regulation
Sci. Signal., August 9, 2005; 2005(296): re11 - re11.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.